Empagliflozin – Insulin Independent Control of Glycaemic Parameters in Diabetes Mellitus Type 2 by Inhibition of the Sodium Glucose Linked Transporter SGLT2
Empagliflozin – Insulin Independent Control of Glycaemic Parameters in Diabetes Mellitus Type 2 by Inhibition of the Sodium Glucose Linked Transporter SGLT2